OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 51 filers reported holding OVID THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $1,445,000 | +28.1% | 348,263 | 0.0% | 0.23% | +27.7% |
Q3 2019 | $1,128,000 | +45.9% | 348,263 | -16.7% | 0.18% | +240.4% |
Q2 2019 | $773,000 | +4.5% | 417,857 | 0.0% | 0.05% | -27.8% |
Q1 2019 | $740,000 | +16.7% | 417,857 | +273.7% | 0.07% | +71.4% |
Q3 2018 | $634,000 | -70.9% | 111,826 | -59.9% | 0.04% | -78.5% |
Q2 2018 | $2,177,000 | +2431.4% | 279,040 | +2187.2% | 0.20% | +2337.5% |
Q1 2018 | $86,000 | -41.9% | 12,200 | -18.7% | 0.01% | -42.9% |
Q4 2017 | $148,000 | – | 15,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 2,000,000 | $7,820,000 | 4.09% |
BVF INC/IL | 6,631,051 | $25,927,000 | 0.97% |
EcoR1 Capital, LLC | 6,082,200 | $23,781,000 | 0.89% |
GLOBEFLEX CAPITAL L P | 1,009,125 | $3,946,000 | 0.71% |
Ikarian Capital, LLC | 1,124,872 | $4,398,000 | 0.36% |
CHI Advisors LLC | 218,510 | $854,000 | 0.20% |
Artal Group S.A. | 2,500,000 | $9,775,000 | 0.20% |
DCF Advisers, LLC | 139,701 | $546,000 | 0.19% |
Tibra Equities Europe Ltd | 78,700 | $308,000 | 0.10% |
XTX Topco Ltd | 50,569 | $198,000 | 0.07% |